ReviewCurrent treatment options in oncology2026

Breakthroughs in HBV-related HCC Therapy: The Unmatched Potential of Immune Checkpoint Inhibitors.

Chenlu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.